| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-08 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.29 | 4e-07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.23 | 7e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.28 | 1e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.21 | 5e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-05 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-05 |